| Michael A Mcdonald, MD | |
|
100 Innovation Drive, Suite 101, Slippery Rock, PA 16057-0000 | |
| (724) 794-4023 | |
| (724) 794-3657 |
| Full Name | Michael A Mcdonald |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 100 Innovation Drive, Slippery Rock, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679563530 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD046378L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael A Mcdonald, MD 100 Innovation Drive, Suite 101, Slippery Rock, PA 16057-0000 Ph: (724) 794-4023 | Michael A Mcdonald, MD 100 Innovation Drive, Suite 101, Slippery Rock, PA 16057-0000 Ph: (724) 794-4023 |
News Archive
Oncotarget recently published "Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment" which reported that a retrospective study included 955 patients of various stages of prostate cancer who received combined hormone radiation treatment from 2000 to 2019.
Frequent measurement of blood flow changes could improve the ability of health care providers to diagnose and treat patients with vascular conditions, such as those associated with diabetes and high blood pressure.
New research presented at this year's Euroanaesthesia congress in Vienna, Austria (1-3 June) shows that mortality in patients who had undergone heart bypass surgery was over 4 times higher in individuals with a high body fat mass, while body mass index (BMI) by itself was not associated with an increase in mortality.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds significant trends in multiple epidemiological parameters to be driving the increase in drug-treatment opportunities for pancreatic cancer over the period 2009 to 2024, including population aging, increasing risk of recurrence following resection and modest improvements in survival.
› Verified 7 days ago
Thomas James Stancik Jr., D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 100 Innovation Drive, Suite 101, Slippery Rock, PA 16057 Phone: 724-794-4023 Fax: 724-794-3675 | |
Dr. Robin L Plank, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Innovation Drive, Suite 101, Slippery Rock, PA 16057 Phone: 724-794-4023 Fax: 724-794-3675 | |
Megan Renee Nash, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Innovation Drive, Suite 101, Slippery Rock, PA 16057 Phone: 724-794-4023 | |
Dr. Glenn M Uber, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Innovation Dr, Suite 101, Slippery Rock, PA 16057 Phone: 724-794-4023 Fax: 724-794-3675 |